Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
ROIV
Roivant Sciences Ltd.
NASDAQ · Pharmaceutical Preparations
Last close
$36.57
· 2026-09-30
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
Pharmaceutical Preparations
Market cap
$26.42B
RECENT INSIDER TRADES
2026-10-05
· Epperly Melissa B,
(Director)
· SELL
2026-10-05
· Epperly Melissa B,
(Director)
· OTHER
2026-10-02
· Gline Matthew
(CEO)
· OTHER
2026-10-02
· Venker Eric
(President & Immunovant CEO)
· SELL
INSTITUTIONAL OWNERSHIP
Institutional holders
529
Shares held
643,968,077
Value
$20.93B
Percent of shares outstanding
89.15%
As of quarter end
2026-06-30
RECENT NEWS
Cantor Fitzgerald reiterates Roivant Sciences stock rating
Roivant announces proof-of-concept results for IMVT-1402 in cutaneous lupus
Roivant Sciences presents at Bank of America healthcare conference
Stifel initiates Roivant Sciences with buy rating, $51 target
Roivant Sciences offers biotech exposure through Vants
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Roivant Sciences Ltd. (ROIV) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit